
New Covid boosters from Pfizer and Moderna designed to target the XBB.1.5 subvariant have been approved by the US Food and Drug Administration and are expected to be made available later this week.
Health officials say that the Centers for Disease Control and Prevention will now sign off on it amid rising cases of Covid across the US.